ArticleFrontiers in medicine2025

Neuromedin B identified as a therapeutic target for atopic dermatitis: evidence from Mendelian randomization and PCR validation.

Lingling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.